$CE

Celanese Corporation (CE) Raises 2026 Free Cash Flow Outlook to $750M–$800M

Celanese reported Q3 2026 adjusted EPS of $1.65 and net sales of $2.6B, up 6% YoY. It raised full-year free cash flow guidance to $750M–$800M and expects adjusted EPS of $6.00–$6.25. The company is focusing on cash generation and deleveraging.

Original reporting
Published Nov 2, 2026, 9:15 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 2, 2026, 9:24 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Celanese Corporation (CE) Raises 2026 Free Cash Flow Outlook to $750M–$800M — source image
Decision brief

The 30-second read

$CEBullishHigh
01

Why it matters

The guidance upgrade is a primary earnings disclosure that can shift valuation multiples and attract cash‑flow focused investors.

02

Market read

First‑report earnings guidance lift; likely to move CE and influence related industrial stocks.

03

What to watch

Potential downside from higher input costs or slower demand could temper the rally.

Relevance 8/10Novelty 8/10Timing: after-hours

Background

Celanese reported Q3 2026 results with EPS $1.65 and sales $2.6B, then upgraded its full‑year free cash flow guidance.

Company-level read

Ticker impact

$CEBullishHigh confidence
Context

Celanese raised its 2026 free cash flow outlook to $750M‑$800M and forecast adjusted EPS of $6.00‑$6.25, a fresh guidance upgrade.

Expected impact

upward pressure as investors price in higher cash flow expectations

Evidence & confidence

The new cash‑flow range is materially above prior guidance and is the first public disclosure.

Market effects

Improves outlook for the specialty chemicals sector as cash‑flow strength may signal demand resilience.

Neutral to US market; could lift peers with similar exposure to industrial demand.

Limited to investors tracking mid‑cap industrials and cash‑flow driven strategies.

Counterpoint

If the cash‑flow boost reflects one‑off cost reductions, the upside may be overstated.

Key entities

  • Celanese Corporation

    US‑listed specialty chemicals producer (ticker CE).

Related articles

$CEMed

Celanese: Q3 Earnings Snapshot

Celanese Corporation (CE) reported Q3 earnings of $74M, or $1.65 per share adjusted, exceeding analyst expectations of $1.52. Revenue was $2.56B, slightly below forecasts. The company expects full-year earnings of $6 to $6.25 per share.

$CEHighAI 8/10

Celanese beats profit estimates with strong cash generation

Celanese (NYSE:CE) reported Q3 adjusted EPS of $1.65, beating estimates, but revenue of $2.56B missed expectations. Net sales rose 6% YoY. The company raised its full-year 2026 adjusted EPS guidance to $6.00-$6.25 and increased its free cash flow outlook to $750M-$800M. Shares gained 1.9% in after-hours trading. Celanese also announced a $152M deal to sell part of its Nutrinova joint venture.

$CEHigh

Celanese Corporation Reports Third Quarter Earnings

Celanese Corp (CE) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Celanese Corporation Reports Third Quarter Earnings; Exceeds Third Quarter Guidance and Raises Full Year Outlook Dallas, November 2, 2026: Celanese Corporation (NYSE: CE), a global chemical and specialty materials company, today reported third quarter 2026 U.S. GAAP

$CEMed

Celanese stock falls after raising LCP prices globally

Celanese Corporation (NYSE:CE) shares dropped 4.3% after hours on Friday after the company announced global price increases for its liquid crystal polymer (LCP) products. The increases, effective immediately, range from $0.45 to $3.50 per unit depending on the product and region. The company cited strong demand, rising costs, and supply chain disruptions as reasons for the price adjustments. Celanese reported 2025 net sales of $9.5 billion.

$CEHighAI 8/10

Why is Celanese stock rallying today?

Celanese (CE) shares rose 7.5% after announcing immediate price hikes for key products in multiple regions, seen as a catalyst for margin recovery. The move is part of broader restructuring efforts, including asset sales. The company maintained its 2026 EPS guidance. The rally is company-specific, not driven by broader market trends. CE operates as a major producer of acetic acid and vinyl acetate monomer.